FAQs and System Test
BrainStorm Therapeutics Top Line Phase 2 Study of NurOwn® in Patients with ALS
Mon, Jul 18, 2016 9:40 AM EDT
Already Registered? Log In Now
Complete this form to enter the webcast.
(* indicates required field)